Drugs / Aspirin Enteric-coated Tablets
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy3 trials | ||||||
| Phase 4 | NCT03072121 Background | Jun 2017 → Dec 2018 | coronary artery disorder | Jun Li | Unknown | No outcome recorded |
| Phase 4 | NCT01762163 Background | Oct 2013 → Oct 2016 | ischemic stroke | China Academy of Chinese Medical Sciences | Completed | No outcome recorded |
| Phase 4 | NCT01513070 Comparator | Apr → Jul 2012 | coronary stenosis | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aspirin Enteric-coated Tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01513070 ↗ |
| Route | Oral | “Aspirin Enteric-coated Tablets，100mg，qd，po. for six months” NCT01513070 ↗ |